Filing Details
CorMedix Inc. (NASDAQ:CRMD) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:CRMD
CorMedix Inc. (CRMD) Files Quarterly Report for Q0
CorMedix Inc. (NASDAQ:CRMD) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
At publication ·
What changed
CorMedix Inc. (NASDAQ:CRMD) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- CorMedix Inc. (NASDAQ: CRMD) filed its quarterly 10-Q report on August 13, 2026, providing unaudited financial statements and management commentary on recent business performance.
- The company's stock trades at $8.14 with a market capitalization of $924.2 million as of the filing date.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last annual report, though with less detail than the annual 10-K.
Market Context
CorMedix Inc.'s stock currently trades at $8.14 with a market capitalization of $924.2M.
The 10-Q provides CorMedix Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for CorMedix Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CRMD Stock Page
Frequently Asked Questions
Where can I read CRMD's SEC filings?
Browse all filings on our CRMD SEC filings page.
What types of SEC filings does CorMedix Inc. file?
Public companies like CorMedix Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.